NDC 71335-1916 – Lamivudine and Zidovudine

Lamivudine 150 mg/1; Zidovudine 300 mg/1 · Tablet · Oral

Human Prescription Drug

Product NDC71335-1916

Product details

Brand name
Lamivudine and Zidovudine
Generic name
Lamivudine and Zidovudine
Labeler
Bryant Ranch Prepack
Dosage form
Tablet
Route
Oral
Marketing category
ANDA · ANDA090679
Marketed since
August 30, 2018
Listing expires
December 31, 2026
Pharmacologic class
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for LAMIVUDINE and ZIDOVUDINE →

Package NDC codes (3)

Package NDCDescriptionSince
71335-1916-16 TABLET in 1 BOTTLE (71335-1916-1)Jul 15, 2021
71335-1916-260 TABLET in 1 BOTTLE (71335-1916-2)Apr 5, 2024
71335-1916-34 TABLET in 1 BOTTLE (71335-1916-3)Apr 5, 2024

Other LAMIVUDINE and ZIDOVUDINE products